Metropolitan Life Insurance Company (MetLife)’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,526
| Closed | -$46.8K | – | 2036 |
|
|
2024
Q1 | $46.8K | Buy |
3,526
+325
| +10% | +$4.32K | ﹤0.01% | 1438 |
|
|
2023
Q4 | $44.6K | Hold |
3,201
| – | – | ﹤0.01% | 1510 |
|
|
2023
Q3 | $42.4K | Buy |
3,201
+403
| +14% | +$5.34K | ﹤0.01% | 1502 |
|
|
2023
Q2 | $52.5K | Hold |
2,798
| – | – | ﹤0.01% | 1392 |
|
|
2023
Q1 | $40.3K | Hold |
2,798
| – | – | ﹤0.01% | 1519 |
|
|
2022
Q4 | $54.1K | Hold |
2,798
| – | – | ﹤0.01% | 1426 |
|
|
2022
Q3 | $96.1K | Buy |
2,798
+345
| +14% | +$11.9K | ﹤0.01% | 1035 |
|
|
2022
Q2 | $37.5K | Hold |
2,453
| – | – | ﹤0.01% | 1679 |
|
|
2022
Q1 | $56K | Sell |
2,453
-1,946
| -44% | -$44.4K | ﹤0.01% | 1532 |
|
|
2021
Q4 | $162K | Hold |
4,399
| – | – | ﹤0.01% | 2161 |
|
|
2021
Q3 | $207K | Buy |
+4,399
| New | +$207K | ﹤0.01% | 2042 |
|